Clinical Trials Browser

Phase 2 × INDUSTRY × Polycystic Ovary Syndrome × Clear all

NCT05370521 2025-10-09

A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens

Phase 2 Terminated

27 enrolled 18 charts

Adrenal Gland Diseases, Polycystic Ovary Syndrome

NCT06963840 2025-08-29

Ova-All Care

Phase 2 Active not recruiting

Polycystic Ovary Syndrome

NCT03951077 2022-06-08

Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome

Phase 2 Completed

118 enrolled 13 charts

Polycystic Ovary Syndrome

NCT02865915 2021-02-01

MLE4901 vs. Placebo for the Treatment of PCOS

Phase 2 Terminated

55 enrolled 10 charts

Acne Vulgaris, Alopecia, Hirsutism, Menstruation Disturbances, Polycystic Ovary Syndrome

NCT03152591 2021-01-05

PCOS

Phase 2 Completed

29 enrolled 24 charts

Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Hyperandrogenism, Overweight

NCT01872078 2015-10-12

A Study of AZD4901 in Females With Polycystic Ovary Syndrome

Phase 2 Completed

67 enrolled 7 charts

Endocrine System Diseases, Polycystic Ovary Syndrome